Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VTE Prophylaxis”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Large-scale testing (Phase 3)Study completedNCT00168818
What this trial is testing

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 3,494
Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Not applicableStudy completedNCT00831714
What this trial is testing

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Bayer 19,076
Post-approval studies (Phase 4)Study completedNCT00077805
What this trial is testing

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Who this might be right for
Acute Ischemic Stroke
Sanofi
Testing effectiveness (Phase 2)Study completedNCT00398905
What this trial is testing

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 726
Not applicableStudy completedNCT02596230
What this trial is testing

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 7,797
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Post-approval studies (Phase 4)WithdrawnNCT03081169
What this trial is testing

Timing of VTE Prophylaxis in TBI

Who this might be right for
TBI (Traumatic Brain Injury)VTE (Venous Thromboembolism)
Loyola University
Not applicableStudy completedNCT02301793
What this trial is testing

Educating Nurses About Venous Thromboembolism (VTE) Prevention

Who this might be right for
Venous ThromboembolismVenous Thrombosis
Johns Hopkins University 933
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Large-scale testing (Phase 3)Study completedNCT00937820
What this trial is testing

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 87
Post-approval studies (Phase 4)UnknownNCT00699465
What this trial is testing

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
University of Oulu 320
Not applicableWithdrawnNCT03812835
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Who this might be right for
Thrombosis, Deep VeinPulmonary Embolism
Pfizer
Not applicableNot Yet RecruitingNCT07196020
What this trial is testing

Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study

Who this might be right for
Venous ThromboembolismCancer
University of Dublin, Trinity College 380
Large-scale testing (Phase 3)Ended earlyNCT00493896
What this trial is testing

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

Who this might be right for
Venous Thromboembolism
Eastern Virginia Medical School 27
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Not applicableStudy completedNCT02186223
What this trial is testing

The Angel® Catheter Pivotal Clinical Trial

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisVenous Thromboembolism+1 more
BiO2 Medical 172
Not applicableEnded earlyNCT01153698
What this trial is testing

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous ThromboembolismArthroplasty, Replacement
Boehringer Ingelheim 167
Testing effectiveness (Phase 2)Study completedNCT00793234
What this trial is testing

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Who this might be right for
Total Knee Replacement Surgery
ThromboGenics 316
Load More Results